Pharmaceutical industry: Novo Nordisk is suing US rival Eli Lilly

—·5h

Novo Nordisk is taking Eli Lilly to court in the billion-dollar market for weight loss injections. The Danes accuse their rival of misleading advertising.

TickersUSChannelssemiconductors, stocksCountriesgermany, europeCategoriespharma

Open original source ↗

Published

7/21/2026, 1:29:53 PM

Fetched

7/21/2026, 3:08:26 PM

Confidence

60 / 100

Relevance

37 / 100

Trust

—

Language